Patents by Inventor Christopher Pargellis

Christopher Pargellis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fluorinated di-aryl urea compounds
    Patent number: 7279475
    Abstract: Disclosed are compounds of formula(I): wherein R1, R2, W and X of formula(I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: September 14, 2004
    Date of Patent: October 9, 2007
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Pier Francesco Cirillo, Abdelhakim Hammach, Victor Kamhi, Neil Moss, Paul S Riska, Christopher Pargellis
  • METHOD FOR ADMINISTERING BIRB 796 BS
    Publication number: 20070203141
    Abstract: Disclosed are methods of administering BIRB 796 BS, a p38 MAPK inhibitor, at particular dosages.
    Type: Application
    Filed: May 1, 2007
    Publication date: August 30, 2007
    Applicant: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
    Inventors: Peter Grob, Jeffrey Madwed, Christopher Pargellis, Chan Yong
  • Fluorinated di-aryl urea compounds
    Patent number: 6872726
    Abstract: Disclosed are compounds of formula (I): wherein R1, R2, W and X of formula (I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: March 29, 2005
    Assignee: Boehringer Ingelheim Pharmaceuticals Inc.
    Inventors: Pier Francesco Cirillo, Abdelhakim Hammach, Victor Kamhi, Neil Moss, Paul S. Riska, Christopher Pargellis
  • Fluorinated di-aryl urea compounds
    Publication number: 20050032797
    Abstract: Disclosed are compounds of formula(I): wherein R1, R2, W and X of formula(I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: September 14, 2004
    Publication date: February 10, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Pier Cirillo, Abdelhakim Hammach, Victor Kamhi, Neil Moss, Paul Riska, Christopher Pargellis
  • Fluorinated di-aryl urea compounds
    Publication number: 20040077647
    Abstract: Disclosed are compounds of formula (I): 1
    Type: Application
    Filed: August 1, 2003
    Publication date: April 22, 2004
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Pier Francesco Cirillo, Abdelhakim Hammach, Victor Kamhi, Neil Moss, Paul S. Riska, Christopher Pargellis
  • Method for administering BIRB 796 BS
    Publication number: 20030118575
    Abstract: Disclosed are methods of administering BIRB 796 BS, a p38 MAPK inhibitor, at particular dosages.
    Type: Application
    Filed: December 6, 2002
    Publication date: June 26, 2003
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Peter M. Grob, Jeffrey B. Madwed, Christopher Pargellis, Chan Loi Yong
  • Aromatic heterocyclic compounds and their use as anti-inflammatory agents
    Publication number: 20010039290
    Abstract: Novel aromatic heterocyclic compounds inhibit cytokines production involved in immunoregulation and inflammation such as interleukin-1 and tumor necrosis factor production. The compounds are therefore useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases.
    Type: Application
    Filed: March 14, 2001
    Publication date: November 8, 2001
    Inventors: John R. Regan, Eugene R. Hickey, Neil Moss, Charles L. Cywin, Christopher Pargellis, Thomas A. Gilmore
  • Aromatic heterocyclic compounds and their use as anti-inflammatory agents
    Patent number: 6228881
    Abstract: Novel aromatic heterocyclic compounds inhibit cytokines production involved in immunoregulation and inflammation such as interleukin-1 and tumor necrosis factor production. The compounds are therefore useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: May 8, 2001
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: John R. Regan, Pier F. Cirillo, Eugene R. Hickey, Neil Moss, Charles L. Cywin, Christopher Pargellis, Thomas A. Gilmore
  • Aromatic heterocyclic compounds and their use as anti-inflammatory agents
    Patent number: 6080763
    Abstract: Novel aromatic heterocyclic compounds inhibit cytokines production involved in immunoregulation and inflammation such as interleukin-1 and tumor necrosis factor production. The compounds are therefore useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases.
    Type: Grant
    Filed: October 29, 1998
    Date of Patent: June 27, 2000
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: John R. Regan, Pier F. Cirillo, Eugene R. Hickey, Neil Moss, Charles L. Cywin, Christopher Pargellis, Thomas A. Gilmore